Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 354

1.

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.

Home PD, Dain MP, Freemantle N, Kawamori R, Pfohl M, Brette S, Pilorget V, Scherbaum WA, Vespasiani G, Vincent M, Balkau B.

Diabetes Res Clin Pract. 2015 Jan 23. pii: S0168-8227(15)00050-9. doi: 10.1016/j.diabres.2015.01.030. [Epub ahead of print]

2.

Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study.

Balkau B, Calvi-Gries F, Freemantle N, Vincent M, Pilorget V, Home PD.

Diabetes Res Clin Pract. 2015 Mar 12. pii: S0168-8227(15)00135-7. doi: 10.1016/j.diabres.2015.02.034. [Epub ahead of print]

3.

Ophthalmic statistics note 6: effect sizes matter.

Cook JA, Bunce C, Doré CJ, Freemantle N; on behalf of the Ophthalmic Statistics Group.

Br J Ophthalmol. 2015 Feb 26. pii: bjophthalmol-2014-306303. doi: 10.1136/bjophthalmol-2014-306303. [Epub ahead of print] No abstract available.

4.

The effect of C-reactive protein reduction with a highly specific antisense oligonucleotide on atrial fibrillation assessed using beat-to-beat pacemaker Holter follow-up.

Sugihara C, Freemantle N, Hughes SG, Furniss S, Sulke N.

J Interv Card Electrophysiol. 2015 Feb 25. [Epub ahead of print]

PMID:
25711952
5.

The Men's Safer Sex (MenSS) trial: protocol for a pilot randomised controlled trial of an interactive digital intervention to increase condom use in men.

Bailey JV, Webster R, Hunter R, Freemantle N, Rait G, Michie S, Estcourt C, Anderson J, Gerressu M, Stephenson J, Ang CS, Hart G, Dhanjal S, Murray E.

BMJ Open. 2015 Feb 16;5(2):e007552. doi: 10.1136/bmjopen-2014-007552.

6.

An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Hunter RM, Baio G, Butt T, Morris S, Round J, Freemantle N.

Pharmacoeconomics. 2015 Apr;33(4):355-66. doi: 10.1007/s40273-014-0247-6.

PMID:
25595871
7.

Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery†

Senanayake EL, Howell NJ, Ranasinghe AM, Drury NE, Freemantle N, Frenneaux M, Oelofse T, Green D, Wilson IC, Rooney SJ, Mascaro J, Graham TR, Bhudia S, Lewis M, Pagano D.

Eur J Cardiothorac Surg. 2014 Dec 23. pii: ezu452. [Epub ahead of print]

PMID:
25538197
8.

Ophthalmic statistics note 5: diagnostic tests-sensitivity and specificity.

Saunders LJ, Zhu H, Bunce C, Doré CJ, Freemantle N, Crabb DP; This fifth note from the Ophthalmic Statistics Group illustrates the utility of measurements of sensitivity and specificity in assessing the usefulness of a test for predicting the presence of pathology; on behalf of the Ophthalmic Statistics Group; This fifth note from the Ophthalmic Statistics Group illustrates the utility of measurements of sensitivity and specificity in assessing the usefulness of a test for predicting the presence of pathology.

Br J Ophthalmol. 2014 Dec 8. pii: bjophthalmol-2014-306055. doi: 10.1136/bjophthalmol-2014-306055. [Epub ahead of print] Review.

9.

Market-access agreements for anti-cancer drugs.

van de Vooren K, Curto A, Freemantle N, Garattini L.

J R Soc Med. 2014 Dec 8. pii: 0141076814559626. [Epub ahead of print] No abstract available.

PMID:
25488094
10.

Response to comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.

Balkau B, Home PD, Vincent M, Marre M, Freemantle N.

Diabetes Care. 2014 Dec;37(12):e266. doi: 10.2337/dc14-2152. No abstract available.

PMID:
25414401
11.

Health on the web: randomised controlled trial of online screening and brief alcohol intervention delivered in a workplace setting.

Khadjesari Z, Freemantle N, Linke S, Hunter R, Murray E.

PLoS One. 2014 Nov 19;9(11):e112553. doi: 10.1371/journal.pone.0112553. eCollection 2014.

12.

Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational atlas study.

Garg SK, Admane K, Freemantle N, Odawara M, Pan CY, Misra A, Jarek-Martynowa IR, Abbas-Raza S, Mirasol RC, Perfetti R.

Endocr Pract. 2015 Feb 1;21(2):143-57. doi: 10.4158/EP14079.OR.

PMID:
25297660
13.

Surgeon length of service and risk-adjusted outcomes: linked observational analysis of the UK National Adult Cardiac Surgery Audit Registry and General Medical Council Register.

Hickey GL, Grant SW, Freemantle N, Cunningham D, Munsch CM, Livesey SA, Roxburgh J, Buchan I, Bridgewater B.

J R Soc Med. 2014 Sep;107(9):355-64. doi: 10.1177/0141076814538788.

14.

Ophthalmic Statistics Note 4: analysing data from randomised controlled trials with baseline and follow-up measurements.

Nash R, Bunce C, Freemantle N, Doré CJ, Rogers CA; Ophthalmic Statistics Group.

Br J Ophthalmol. 2014 Nov;98(11):1467-9. doi: 10.1136/bjophthalmol-2014-305614. Epub 2014 Aug 7. No abstract available.

15.

Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study.

Marshall M, Husain N, Bork N, Chaudhry IB, Lester H, Everard L, Singh SP, Freemantle N, Sharma V, Jones PB, Fowler D, Amos T, Tomenson B, Birchwood M.

Schizophr Res. 2014 Oct;159(1):1-6. doi: 10.1016/j.schres.2014.07.005. Epub 2014 Aug 5.

PMID:
25107851
16.

A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial.

Graham HL, Birchwood M, Griffith E, Freemantle N, McCrone P, Stefanidou CA, Walsh K, Clarke L, Rana A, Copello A.

Trials. 2014 Aug 1;15:308. doi: 10.1186/1745-6215-15-308.

17.

Gender differences in survival and the use of primary care prior to diagnosis of three cancers: an analysis of routinely collected UK general practice data.

Wang Y, Freemantle N, Nazareth I, Hunt K.

PLoS One. 2014 Jul 11;9(7):e101562. doi: 10.1371/journal.pone.0101562. eCollection 2014.

18.

The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial.

Drury NE, Howell NJ, Calvert MJ, Weber RJ, Senanayake EL, Lewis ME, Hyde JA, Green DH, Mascaro JG, Wilson IC, Graham TR, Rooney SJ, Viant MR, Freemantle N, Frenneaux MP, Pagano D; investigators.

Eur J Cardiothorac Surg. 2015 Mar;47(3):464-72. doi: 10.1093/ejcts/ezu238. Epub 2014 Jun 19.

19.

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.

Ng KP, Jain P, Heer G, Redman V, Chagoury OL, Dowswell G, Greenfield S, Freemantle N, Townend JN, Gill PS, McManus RJ, Ferro CJ.

Trials. 2014 May 6;15:158. doi: 10.1186/1745-6215-15-158.

20.

Factors associated with weight gain in people with type 2 diabetes starting on insulin.

Balkau B, Home PD, Vincent M, Marre M, Freemantle N.

Diabetes Care. 2014 Aug;37(8):2108-13. doi: 10.2337/dc13-3010. Epub 2014 May 13.

PMID:
24824546
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk